Hunter NB, Peterson LM, Specht JM, Mankoff DA, et al. Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer. Breast Cancer Res 2025;27:23.
PMID: 39962532